RINGO WILLIAM R
Insider CIK 1238325 · SGMO Director · ONXX Director · FPRX Interim CEO, Director · VTUS Director · IMDZ Director · DERM Director · MRTX Director · SNSE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2025-06-05 | 2025-06-09 | 3,500 | — | $0 | 3,500 | SEC↗ |
| SNSE Sensei Biotherapeutics, In | A Award deriv | 2025-05-21 | 2025-05-23 | 19,000 | — | $0 | 19,000 | SEC↗ |
| SNSE Sensei Biotherapeutics, In | A Award deriv | 2024-06-11 | 2024-06-13 | 19,000 | — | $0 | 19,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2024-05-29 | 2024-05-30 | 2,750 | — | $0 | 2,750 | SEC↗ |
| SNSE Sensei Biotherapeutics, In | A Award deriv | 2023-07-10 | 2023-07-12 | 14,550 | — | $0 | 14,550 | SEC↗ |
| SNSE Sensei Biotherapeutics, In | A Award | 2023-07-10 | 2023-07-12 | 4,466 | — | $0 | 23,399 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2023-05-25 | 2023-05-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2022-05-25 | 2022-05-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SNSE Sensei Biotherapeutics, In | A Award deriv | 2022-03-08 | 2022-03-09 | 29,100 | — | $0 | 29,100 | SEC↗ |
| SNSE Sensei Biotherapeutics, In | A Award | 2022-03-08 | 2022-03-09 | 10,000 | — | $0 | 18,933 | SEC↗ |
| SNSE Sensei Biotherapeutics, In | A Award | 2022-03-08 | 2022-03-09 | 8,933 | — | $0 | 8,933 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2021-05-20 | 2021-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 46,939 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 52,408 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 37,998 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 40,868 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 49,552 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 50,367 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 27,769 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 34,451 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 15,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 10,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 10,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 12,500 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 16,600 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | G Gift | 2021-04-05 | 2021-04-19 | 10,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | M Exercise deriv | 2020-11-11 | 2020-11-13 | 26,000 | — | $0 | 52,408 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | M Exercise deriv | 2020-11-11 | 2020-11-13 | 52,959 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | M Exercise | 2020-11-11 | 2020-11-13 | 26,000 | $2.80 | $72.8K | 36,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | S Sale | 2020-11-11 | 2020-11-13 | 26,000 | $22.50 | $585.0K | 10,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | S Sale | 2020-11-11 | 2020-11-13 | 52,959 | $22.50 | $1.19M | 10,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | M Exercise | 2020-11-11 | 2020-11-13 | 52,959 | $2.22 | $117.6K | 62,959 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2020-06-11 | 2020-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2020-05-19 | 2020-05-20 | 27,769 | — | $0 | 27,769 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2020-04-19 | 2020-04-20 | 78,408 | — | $0 | 78,408 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2020-03-19 | 2020-03-20 | 52,959 | — | $0 | 52,959 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | G Gift | 2020-02-28 | 2020-06-15 | 2,000 | — | $0 | 17,465 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 6,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 6,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 3,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 18,275 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 8,620 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 10,344 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 6,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer | 2020-02-20 | 2020-02-24 | 6,000 | $18.75 | $112.5K | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2020-02-19 | 2020-02-20 | 37,998 | — | $0 | 37,998 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2020-01-20 | 2020-01-21 | 40,868 | — | $0 | 40,868 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2020-01-20 | 2020-01-21 | 40,868 | — | $0 | 40,868 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2019-12-19 | 2019-12-20 | 49,552 | — | $0 | 49,552 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2019-11-19 | 2019-11-20 | 50,367 | — | $0 | 50,367 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2019-10-19 | 2019-10-21 | 46,939 | — | $0 | 46,939 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2019-10-05 | 2019-10-08 | 34,451 | — | $0 | 34,451 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2019-06-12 | 2019-06-14 | 3,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2019-06-12 | 2019-06-14 | 3,000 | — | $0 | 6,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2019-06-10 | 2019-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2019-06-04 | 2019-06-06 | 3,000 | — | $0 | 3,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2019-06-04 | 2019-06-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2019-05-17 | 2019-05-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IMDZ IMMUNE DESIGN CORP. | D To issuer deriv | 2019-04-02 | 2019-04-04 | 10,000 | — | $0 | 0 | SEC↗ |
| IMDZ IMMUNE DESIGN CORP. | D To issuer deriv | 2019-04-02 | 2019-04-04 | 12,500 | — | $0 | 0 | SEC↗ |
| IMDZ IMMUNE DESIGN CORP. | D To issuer deriv | 2019-04-02 | 2019-04-04 | 12,500 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2019-01-09 | 2019-01-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IMDZ IMMUNE DESIGN CORP. | A Award deriv | 2019-01-03 | 2019-01-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise deriv | 2018-07-02 | 2018-07-03 | 1,000 | — | $0 | 49,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise | 2018-07-02 | 2018-07-03 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | S Sale | 2018-07-02 | 2018-07-03 | 1,000 | $38.50 | $38.5K | 19,465 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2018-06-13 | 2018-06-14 | 3,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2018-06-13 | 2018-06-14 | 3,000 | — | $0 | 3,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2018-06-12 | 2018-06-14 | 6,000 | — | $0 | 6,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2018-06-12 | 2018-06-14 | 3,000 | — | $0 | 3,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise deriv | 2018-06-01 | 2018-06-01 | 1,000 | — | $0 | 50,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise | 2018-06-01 | 2018-06-01 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | S Sale | 2018-06-01 | 2018-06-01 | 1,000 | $42.47 | $42.5K | 19,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2018-05-30 | 2018-06-01 | 7,500 | — | $0 | 7,500 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2018-05-10 | 2018-05-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise deriv | 2018-05-01 | 2018-05-02 | 1,000 | — | $0 | 51,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise | 2018-05-01 | 2018-05-02 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | S Sale | 2018-05-01 | 2018-05-02 | 1,000 | $43.06 | $43.1K | 19,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise deriv | 2018-04-02 | 2018-04-02 | 1,000 | — | $0 | 52,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | S Sale | 2018-04-02 | 2018-04-02 | 1,000 | $49.32 | $49.3K | 19,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise | 2018-04-02 | 2018-04-02 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise deriv | 2018-03-01 | 2018-03-02 | 1,000 | — | $0 | 53,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | S Sale | 2018-03-01 | 2018-03-02 | 1,000 | $56.37 | $56.4K | 19,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise | 2018-03-01 | 2018-03-02 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise deriv | 2018-02-01 | 2018-02-02 | 1,000 | — | $0 | 54,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | S Sale | 2018-02-01 | 2018-02-02 | 1,000 | $46.86 | $46.9K | 19,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise | 2018-02-01 | 2018-02-02 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| IMDZ Immune Design Corp. | A Award deriv | 2018-01-04 | 2018-01-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise deriv | 2018-01-02 | 2018-01-03 | 1,000 | — | $0 | 55,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | S Sale | 2018-01-02 | 2018-01-03 | 1,000 | $45.04 | $45.0K | 19,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise | 2018-01-02 | 2018-01-03 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise deriv | 2017-12-01 | 2017-12-04 | 1,000 | — | $0 | 56,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | S Sale | 2017-12-01 | 2017-12-04 | 1,000 | $49.37 | $49.4K | 19,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise | 2017-12-01 | 2017-12-04 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2017-11-01 | 2017-11-02 | 600 | — | $0 | 16,600 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise deriv | 2017-11-01 | 2017-11-03 | 1,000 | — | $0 | 57,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2017-11-01 | 2017-11-02 | 600 | $11.65 | $7.0K | 600 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2017-11-01 | 2017-11-02 | 600 | $45.33 | $27.2K | 0 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise | 2017-11-01 | 2017-11-03 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | S Sale | 2017-11-01 | 2017-11-03 | 1,000 | $29.55 | $29.6K | 19,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise deriv | 2017-10-16 | 2017-10-17 | 1,000 | — | $0 | 58,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise | 2017-10-16 | 2017-10-17 | 1,000 | $7.20 | $7.2K | 20,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | S Sale | 2017-10-16 | 2017-10-17 | 1,000 | $33.70 | $33.7K | 19,465 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2017-10-02 | 2017-10-03 | 600 | — | $0 | 17,200 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2017-10-02 | 2017-10-03 | 600 | $11.65 | $7.0K | 600 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2017-10-02 | 2017-10-03 | 600 | $40.78 | $24.5K | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2017-09-29 | 2017-10-03 | 1,200 | — | $0 | 17,800 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2017-09-29 | 2017-10-03 | 1,200 | $40.00 | $48.0K | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2017-09-29 | 2017-10-03 | 1,200 | $11.65 | $14.0K | 1,200 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2017-09-28 | 2017-10-02 | 2,000 | — | $0 | 19,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2017-09-28 | 2017-10-02 | 2,000 | $11.65 | $23.3K | 2,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2017-09-28 | 2017-10-02 | 2,000 | $38.00 | $76.0K | 0 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | M Exercise deriv | 2017-09-20 | 2017-09-22 | 31,000 | — | $0 | 0 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | M Exercise | 2017-09-20 | 2017-09-22 | 31,000 | $6.05 | $187.6K | 31,800 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | S Sale | 2017-09-20 | 2017-09-22 | 31,000 | $14.37 | $445.5K | 800 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | G Gift | 2017-06-23 | 2017-10-17 | 1,000 | — | $0 | 19,465 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2017-06-13 | 2017-06-15 | 3,000 | — | $0 | 3,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2017-06-13 | 2017-06-15 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2017-06-05 | 2017-06-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2017-06-01 | 2017-06-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | S Sale | 2017-05-12 | 2017-05-16 | 3,461 | $22.00 | $76.1K | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2017-05-10 | 2017-05-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise deriv | 2017-05-10 | 2017-05-12 | 5,000 | — | $0 | 59,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | G Gift | 2017-05-10 | 2017-05-12 | 3,461 | — | $0 | 20,465 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | F Tax w/h | 2017-05-10 | 2017-05-12 | 1,539 | $23.39 | $36.0K | 23,926 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | G Gift | 2017-05-10 | 2017-05-12 | 3,461 | — | $0 | 3,461 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | M Exercise | 2017-05-10 | 2017-05-12 | 5,000 | $7.20 | $36.0K | 25,465 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-05-01 | 2017-05-03 | 500 | — | $0 | 18,275 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-05-01 | 2017-05-03 | 500 | $34.06 | $17.0K | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-05-01 | 2017-05-03 | 500 | $16.00 | $8.0K | 500 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-04-03 | 2017-04-04 | 500 | — | $0 | 18,775 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-04-03 | 2017-04-04 | 500 | $16.00 | $8.0K | 500 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-04-03 | 2017-04-04 | 500 | $34.03 | $17.0K | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2017-03-01 | 2017-03-01 | 500 | — | $0 | 21,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-03-01 | 2017-03-02 | 500 | — | $0 | 19,275 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2017-03-01 | 2017-03-01 | 500 | $11.65 | $5.8K | 500 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2017-03-01 | 2017-03-01 | 500 | $46.73 | $23.4K | 0 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-03-01 | 2017-03-02 | 500 | $35.09 | $17.5K | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-03-01 | 2017-03-02 | 500 | $16.00 | $8.0K | 500 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-02-15 | 2017-02-16 | 500 | — | $0 | 19,775 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-02-15 | 2017-02-16 | 500 | $16.00 | $8.0K | 500 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-02-15 | 2017-02-16 | 500 | $32.00 | $16.0K | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2017-02-01 | 2017-02-01 | 500 | — | $0 | 21,500 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2017-02-01 | 2017-02-01 | 500 | $46.17 | $23.1K | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2017-02-01 | 2017-02-01 | 500 | $11.65 | $5.8K | 500 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-01-04 | 2017-01-04 | 500 | — | $0 | 20,275 | SEC↗ |
| IMDZ Immune Design Corp. | A Award deriv | 2017-01-04 | 2017-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2017-01-04 | 2017-01-04 | 500 | $32.00 | $16.0K | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-01-04 | 2017-01-04 | 500 | $16.00 | $8.0K | 500 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2017-01-03 | 2017-01-03 | 500 | — | $0 | 22,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2017-01-03 | 2017-01-03 | 500 | $51.07 | $25.5K | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2017-01-03 | 2017-01-03 | 500 | $11.65 | $5.8K | 500 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2016-12-16 | 2016-12-16 | 125 | — | $0 | 20,775 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2016-12-16 | 2016-12-16 | 125 | $16.00 | $2.0K | 125 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-12-16 | 2016-12-16 | 125 | $32.00 | $4.0K | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2016-12-01 | 2016-12-02 | 375 | — | $0 | 20,900 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-12-01 | 2016-12-02 | 500 | — | $0 | 22,500 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-12-01 | 2016-12-02 | 375 | $32.00 | $12.0K | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2016-12-01 | 2016-12-02 | 375 | $16.00 | $6.0K | 375 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-12-01 | 2016-12-02 | 500 | $11.65 | $5.8K | 500 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-12-01 | 2016-12-02 | 500 | $57.72 | $28.9K | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2016-11-09 | 2016-11-10 | 500 | — | $0 | 21,275 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2016-11-09 | 2016-11-10 | 500 | $16.00 | $8.0K | 500 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-11-09 | 2016-11-10 | 500 | $32.30 | $16.1K | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-11-01 | 2016-11-02 | 500 | — | $0 | 23,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-11-01 | 2016-11-02 | 500 | $11.65 | $5.8K | 500 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-11-01 | 2016-11-02 | 500 | $48.67 | $24.3K | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-10-03 | 2016-10-04 | 500 | — | $0 | 23,500 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2016-10-03 | 2016-10-04 | 500 | — | $0 | 21,775 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-10-03 | 2016-10-04 | 500 | $52.00 | $26.0K | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-10-03 | 2016-10-04 | 500 | $11.65 | $5.8K | 500 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2016-10-03 | 2016-10-04 | 500 | $16.00 | $8.0K | 500 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-10-03 | 2016-10-04 | 500 | $34.25 | $17.1K | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2016-09-01 | 2016-09-02 | 500 | — | $0 | 22,275 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale deriv | 2016-09-01 | 2016-09-02 | 500 | — | $0 | 24,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2016-09-01 | 2016-09-02 | 500 | $16.00 | $8.0K | 500 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-09-01 | 2016-09-02 | 500 | $32.00 | $16.0K | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-09-01 | 2016-09-02 | 500 | $44.20 | $22.1K | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-09-01 | 2016-09-02 | 500 | $11.65 | $5.8K | 500 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale deriv | 2016-08-01 | 2016-08-02 | 500 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2016-08-01 | 2016-08-03 | 500 | — | $0 | 22,775 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-08-01 | 2016-08-02 | 500 | $11.65 | $5.8K | 500 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-08-01 | 2016-08-02 | 500 | $50.77 | $25.4K | 0 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-08-01 | 2016-08-03 | 500 | $33.65 | $16.8K | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2016-08-01 | 2016-08-03 | 500 | $16.00 | $8.0K | 500 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2016-06-21 | 2016-06-23 | 10,344 | — | $0 | 10,344 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | A Award deriv | 2016-06-14 | 2016-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2016-06-02 | 2016-06-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2016-05-19 | 2016-05-23 | 10,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2016-05-18 | 2016-05-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IMDZ Immune Design Corp. | A Award deriv | 2016-01-04 | 2016-01-06 | 9,300 | — | $0 | 9,300 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise deriv | 2015-06-22 | 2015-06-24 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2015-06-12 | 2015-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2015-06-11 | 2015-06-15 | 8,620 | — | $0 | 8,620 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise deriv | 2015-06-03 | 2015-06-03 | 2,200 | — | $0 | 31,000 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise | 2015-06-03 | 2015-06-03 | 2,200 | $6.05 | $13.3K | 3,000 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | S Sale | 2015-06-03 | 2015-06-03 | 2,200 | $12.44 | $27.4K | 800 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2015-05-28 | 2015-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2015-05-21 | 2015-05-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise deriv | 2015-05-04 | 2015-05-05 | 1,200 | — | $0 | 0 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise deriv | 2015-05-04 | 2015-05-05 | 1,800 | — | $0 | 33,200 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise | 2015-05-04 | 2015-05-05 | 1,200 | $6.41 | $7.7K | 2,000 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | S Sale | 2015-05-04 | 2015-05-05 | 3,000 | $12.98 | $38.9K | 800 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise | 2015-05-04 | 2015-05-05 | 1,800 | $6.05 | $10.9K | 3,800 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise deriv | 2015-04-06 | 2015-04-08 | 2,200 | — | $0 | 1,200 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | S Sale | 2015-04-06 | 2015-04-08 | 2,200 | $14.95 | $32.9K | 800 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise | 2015-04-06 | 2015-04-08 | 2,200 | $6.41 | $14.1K | 3,000 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise deriv | 2015-03-03 | 2015-03-04 | 2,200 | — | $0 | 3,400 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise | 2015-03-03 | 2015-03-04 | 2,200 | $6.41 | $14.1K | 3,000 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | S Sale | 2015-03-03 | 2015-03-04 | 2,200 | $17.21 | $37.9K | 800 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise deriv | 2015-02-03 | 2015-02-05 | 2,200 | — | $0 | 5,600 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise | 2015-02-03 | 2015-02-05 | 2,200 | $6.41 | $14.1K | 3,000 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | S Sale | 2015-02-03 | 2015-02-05 | 2,200 | $12.70 | $27.9K | 800 | SEC↗ |
| IMDZ Immune Design Corp. | A Award deriv | 2015-01-07 | 2015-01-09 | 9,300 | — | $0 | 9,300 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise deriv | 2015-01-05 | 2015-01-06 | 2,200 | — | $0 | 7,800 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | S Sale | 2015-01-05 | 2015-01-06 | 2,200 | $15.20 | $33.4K | 800 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise | 2015-01-05 | 2015-01-06 | 2,200 | $6.41 | $14.1K | 3,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2014-10-02 | 2014-10-02 | 23,275 | — | $0 | 23,275 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2014-10-01 | 2014-10-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2014-09-09 | 2014-09-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ASMB ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2014-07-10 | 2014-10-07 | 64,000 | — | $0 | 64,000 | SEC↗ |
| VTUS ASSEMBLY BIOSCIENCES, INC. | A Award deriv | 2014-07-10 | 2014-07-14 | 64,000 | — | $0 | 64,000 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | A Award deriv | 2014-04-21 | 2014-04-23 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2014-03-19 | 2014-03-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise deriv | 2014-02-14 | 2014-02-19 | 15,000 | — | $0 | 35,000 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise deriv | 2014-02-14 | 2014-02-19 | 10,000 | — | $0 | 0 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | S Sale | 2014-02-14 | 2014-02-19 | 25,000 | $18.06 | $451.5K | 800 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise | 2014-02-14 | 2014-02-19 | 10,000 | $5.03 | $50.3K | 25,800 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise | 2014-02-14 | 2014-02-19 | 15,000 | $6.05 | $90.8K | 15,800 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 5,417 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 5,000 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 2,000 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2013-10-01 | 2013-10-03 | 5,900 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer | 2013-10-01 | 2013-10-03 | 2,100 | $125.00 | $262.5K | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | U Tender | 2013-10-01 | 2013-10-03 | 7,737 | $125.00 | $967.1K | 2,100 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | A Award deriv | 2013-06-12 | 2013-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award deriv | 2013-03-28 | 2013-04-01 | 5,900 | — | $0 | 5,900 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award | 2013-03-28 | 2013-04-01 | 2,100 | — | $0 | 9,837 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2012-11-07 | 2012-11-08 | 1,300 | $75.01 | $97.5K | 7,737 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2012-08-06 | 2012-08-08 | 767 | — | $0 | 0 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | D To issuer deriv | 2012-08-06 | 2012-08-08 | 7,500 | — | $0 | 12,500 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2012-08-06 | 2012-08-08 | 7,500 | $36.61 | $274.6K | 13,227 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | M Exercise | 2012-08-06 | 2012-08-08 | 767 | $35.18 | $27.0K | 5,727 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | S Sale | 2012-08-06 | 2012-08-08 | 4,190 | $72.27 | $302.8K | 9,037 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award deriv | 2012-07-25 | 2012-07-27 | 2,000 | — | $0 | 2,000 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award | 2012-07-25 | 2012-07-27 | 1,500 | — | $0 | 4,960 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | A Award deriv | 2012-06-21 | 2012-06-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award deriv | 2012-03-30 | 2012-04-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ONXX ONYX PHARMACEUTICALS INC | A Award | 2012-03-30 | 2012-04-03 | 3,000 | — | $0 | 3,460 | SEC↗ |